Please note

Due to the recent spike in Covid-19 cases, we are no longer able to entertain walk-in visits to our headquarters or any of our facilities.

PGB 150mg capsules

Ferron Par Pharmaceuticals

Ingredients in every capsule

Pregabalin 150 mg

Each package contains

3 blisters of 10 capsules

Dosage form

capsule

Dosage formCapsule; hard

Flavour

None

W.H.O. classification

N03A
N03A

A.T.C. Level 1

Anatomical Main group

N - Nervous system
N03A

A.T.C. Level 2

Therapeutic subgroup

N03 - Antiepileptics
N03A

A.T.C. Level 3

Pharmacological subgroup

N03A - Antiepileptics

Available in

Indonesia

Warnings

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

NOT RECOMMENDEDThis item should not be used while operating heavy machinery.

Pregnancy

NOT RECOMMENDEDThis item is not safe for use during pregnancy.

Lactation

NOT RECOMMENDEDThis item is not safe for use during lactation.

Indication

Neuropathic pain
Pregabalin is indicated for the treatment of peripheral and central neuropathic pain in adults. (I p.1, II p.2288, III p.502, IV p.2)
Epilepsy
Pregabalin is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalization. (I p.1, II p.2288, III p.502, IV p.2)
Generalized anxiety disorder
Pregabalin is indicated for the treatment of generalized anxiety disorder (GAD) in adults. (I p.1, III p.502, IV p.2)

Dosage

18 TO 65 YEARS OLD
The dose range is 150 to 600 mg per day given in either two or three divided doses, pregabalin is given with or without food.

If pregabalin has to be discontinued, it is recommended this should be done gradually over a minimum of 1 week independent of the indication.

65 YEARS OLD AND ABOVE
Elderly patients may require a dose reduction of pregabalin due to a decreased renal function

If pregabalin has to be discontinued, it is recommended this should be done gradually over a minimum of 1 week independent of the indication.

PATIENTS WITH RENAL IMPAIRMENT
Dose reduction in patients with compromised renal function must be individualised according to creatinine clearance